dbACP: A Comprehensive Database of Anti-Cancer Peptides

7 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp06208 TAT-DV3-BH3 YGRKKRRQRRRGGGLGASWHRPDKGGGGLRRMADDLNAQY BH3-only, Direct activators (PUMA, Bid) Inducing apoptosis CCK-8 assay HCT116p53–/– Colon cancer Survival rate : 32.19 ± 6.42%
dbacp06209 TAT-DV3-BH3 YGRKKRRQRRRGGGLGASWHRPDKGGGGLRRMADDLNAQY BH3-only, Direct activators (PUMA, Bid) Inducing apoptosis CCK-8 assay HCT116p53+/+ Colon cancer Survival rate : 34.28 ± 8.93%
dbacp06210 TAT-DV3-BH3 YGRKKRRQRRRGGGLGASWHRPDKGGGGLRRMADDLNAQY BH3-only, Direct activators (PUMA, Bid) Inducing apoptosis CCK-8 assay GLC-82 Colon cancer Survival rate : 63.64 ± 4.80%
dbacp06211 TAT-DV3-BH3 YGRKKRRQRRRGGGLGASWHRPDKGGGGLRRMADDLNAQY BH3-only, Direct activators (PUMA, Bid) Inducing apoptosis CCK-8 assay SGC-7901 Colon cancer Survival rate : 64.75 ± 33.48%
dbacp06212 TAT-DV3-BH3 YGRKKRRQRRRGGGLGASWHRPDKGGGGLRRMADDLNAQY BH3-only, Direct activators (PUMA, Bid) Inducing apoptosis CCK-8 assay MDA-MB-231 Colon cancer Survival rate : 69.79 ± 6.71%
dbacp06213 TAT-DV3-BH3 YGRKKRRQRRRGGGLGASWHRPDKGGGGLRRMADDLNAQY BH3-only, Direct activators (PUMA, Bid) Inducing apoptosis CCK-8 assay HEK293 Colon cancer Survival rate : 115.85 ± 23.03%
dbacp06214 TAT-DV3-BH3 YGRKKRRQRRRGGGLGASWHRPDKGGGGLRRMADDLNAQY BH3-only, Direct activators (PUMA, Bid) Inducing apoptosis CCK-8 assay 2BS Colon cancer Survival rate : 124.38 ± 22.05%